Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
10.33
+4.41 (74.49%)
At close: Dec 10, 2025, 4:00 PM EST
9.94
-0.39 (-3.78%)
After-hours: Dec 10, 2025, 7:59 PM EST
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $6.17 million as of December 10, 2025. Its market cap has increased by 86.05% in one year.
Market Cap
6.17M
Enterprise Value
1.94M
1-Year Change
86.05%
Ranking
Category
Stock Price
$10.33
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $6.17M, a decrease of -100.00%. That is a compound annual growth rate of -86.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 6.17M | 69.19% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | 135.21B | - |
| Dec 31, 2020 | 135.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |